scholarly journals The Efficacy of 18F-FDG PET/CT in Detecting Colorectal Cancer Recurrences

2021 ◽  
Vol 37 (4) ◽  
pp. 236-243
Author(s):  
Aysun Küçüköz Uzun ◽  
Tülay Kaçar Güveli ◽  
Filiz Özülker ◽  
Tamer Özülker
Keyword(s):  
Colorectal Cancer ◽  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Improvement of the diagnostic accuracy of lymph node metastases of colorectal cancer in 18F-FDG-PET/CT by optimizing the iteration number for the image reconstruction

2008 ◽  
Vol 22 (6) ◽  
pp. 465-473 ◽  
Author(s):  
Kazumasa Inoue ◽  
Takashi Sato ◽  
Hideaki Kitamura ◽  
Masaaki Ito ◽  
Yoshiyuki Tsunoda ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Lymph Node ◽  
Diagnostic Accuracy ◽  
Lymph Node Metastases ◽  
Fdg Pet ◽  
Pet Ct ◽  
Node Metastases ◽  
18F Fdg ◽  
Iteration Number ◽  
Fdg Pet Ct

W1505: Value of 18F-FDG PET/CT in the Assessment of Lymph Node Metastasis With Early Colorectal Cancer

2010 ◽  
Vol 71 (5) ◽  
pp. AB345
Author(s):  
Si Hyung Lee ◽  
Kyeong Ok Kim ◽  
Byung-Ik Jang ◽  
Tae Nyeun Kim ◽  
Seongwoo Jeon ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Lymph Node ◽  
Lymph Node Metastasis ◽  
Fdg Pet ◽  
Early Colorectal Cancer ◽  
Node Metastasis ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

18F-FDG PET/CT superior to serum CEA in detection of colorectal cancer and its recurrence

2013 ◽  
Vol 37 (6) ◽  
pp. 1094-1097 ◽  
Author(s):  
William Makis ◽  
David Kurzencwyg ◽  
Marc Hickeson
Keyword(s):  
Colorectal Cancer ◽  
Fdg Pet ◽  
Pet Ct ◽  
Serum Cea ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals Usefulness of 18F-FDG PET/CT, LDH and tumor markers in the prognosis and evaluation of tumor response after RMB therapy in advanced, metastatic colorectal cancer (mCRC)

2017 ◽  
Vol 28 ◽  
pp. iii12
Author(s):  
Angelica Nazarian ◽  
Zoe Andrada ◽  
Joanne Thomas ◽  
Sudipta Sureshbabu ◽  
Nathaniel Berman ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Tumor Markers ◽  
Fdg Pet ◽  
Tumor Response ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

Impact of 18F-FDG PET/CT on therapeutic decisions in patients with colorectal cancer and liver metastases

2013 ◽  
Vol 37 (3) ◽  
pp. 536-541 ◽  
Author(s):  
Alexandros Georgakopoulos ◽  
Nikoletta Pianou ◽  
Nikolaos Kelekis ◽  
Sofia Chatziioannou
Keyword(s):  
Colorectal Cancer ◽  
Liver Metastases ◽  
Fdg Pet ◽  
Therapeutic Decisions ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals Role of 18F-FDG PET/CT in the Follow-up of Colorectal Cancer

2020 ◽  
Vol 28 (2) ◽  
pp. 119
Author(s):  
Renata Milardovic ◽  
Nermina Beslic ◽  
Amera Sadija ◽  
Sejla Ceric ◽  
Melika Bukvic ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals The Prognostic Value of SUVmax of 18F-FDG PET/CT in Patients with Metastatic Colorectal Cancer

2020 ◽  
Vol 49 (1) ◽  
pp. 1
Author(s):  
Emir Sokolović ◽  
Timur Cerić ◽  
Šejla Cerić ◽  
Semir Bešlija ◽  
Sandra Vegar-Zubović ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Disease Progression ◽  
Fdg Pet ◽  
Prognostic Value ◽  
Prognostic Markers ◽  
Pet Ct ◽  
Ct Analysis ◽  
18F Fdg ◽  
Fdg Pet Ct

<p><strong>Objective. </strong>The aim of the study was to evaluate the prognostic value of the maximum standardized uptake value (SUVmax) of 18F-Fluorodeoxyglucose (18F-FDG) PET/CT in patients with metastatic colorectal cancer, and to compare it with classical prognostic markers.</p><p><strong>Materials and Methods. </strong>The study included 70 patients with metastatic colorectal cancer who had not been treated for the metastatic disease. The patients underwent 18F-FDG PET/CT as part of their routine diagnostic reevaluation. During the analysis, the value of the largest tumor diameter and SUVmax was determined for the lesion with the highest SUVmax observed. The values of CEA and CA 19-9 were recorded 7 days before the PET/CT analysis.</p><p><strong>Results. </strong>SUVmax and Carbohydrate antigen (CA)19-9 were found to be independent prognostic markers of disease progression within 12 months. Based on the Receiver Operating Characteristics (ROC) curve analysis, the patients could be divided into two groups: SUVmax≤4.1 vs. SUVmax&gt;4.1. Patients with SUVmax values of 4.1 or less had significantly better progression-free survival within 12 months with an HR (95% CI) of 2.97 (1.4-6.3), relative to patients with SUVmax values above 4.1.</p><p><strong>Conclusion. </strong>SUVmax may be used as a novel prognostic marker of disease progression among patients with metastatic colorectal cancer. Values of SUVmax can be used to select patients with a more aggressive type of disease and higher risk for progression within 12 months of PET/CT analysis.</p>

Relationships between hypoxia induced factor-1α and 18F-FDG PET/CT parameters in colorectal cancer

2019 ◽  
Vol 38 (6) ◽  
pp. 355-361
Author(s):  
Zekiye Hasbek ◽  
Hatice Ozer ◽  
Seyit Ahmet Erturk ◽  
Eda Erdiş ◽  
Birsen Yucel ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Fdg Pet ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct

scholarly journals Retrospective analysis of the prognostic value of PD-L1 expression and 18F-FDG PET/CT metabolic parameters in colorectal cancer

2020 ◽  
Vol 11 (10) ◽  
pp. 2864-2873 ◽  
Author(s):  
Hao Jiang ◽  
Rongjun Zhang ◽  
Huijie Jiang ◽  
Mingyu Zhang ◽  
Wei Guo ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Retrospective Analysis ◽  
Fdg Pet ◽  
Prognostic Value ◽  
Metabolic Parameters ◽  
Pet Ct ◽  
18F Fdg ◽  
Fdg Pet Ct
Sign in / Sign up

Export Citation Format

Share Document